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Background: Chagas disease (CD) is endemic in countries of continental Latin America. Congenital transmission is
a major concern worldwide. In 2010, the Public Health Agency of Catalonia (ASPCAT) launched a screening
protocol for Trypanosoma cruzi infection in pregnant women and their newborns. In 2012, ASPCAT detected
appropriate follow-up of pregnant women but incomplete information about their offspring.
Methods: The PROSICS community health team carried out active surveillance and community health action in
target populations. These activities included active case searches, group awareness workshops and visualization
campaigns as well as investigation of all lost children born from pregnant women with CD and their families.
Results: Overall, 42/179 (23.5%) cases were included in the study: 35/42 (83.3%) children were born in Hospitalet de
Llobregat (Catalonia, Spain); 4/42 (16.7%) were born in Latin America; two were miscarried and one was stillborn.
The mean age of pregnant women was 31.3 years (SD 5.52; range: 21–44): 90.5% were Bolivian, of whom 74% were
diagnosed with CD during pregnancy. Of the 35 newborns, 31 were recovered by community health action; 12/31
were correctly controlled at Hospitalet de Llobregat and 19/31 were controlled at a primary health centre. Of these
19 (73.7%) cases, 14 were not tested for CD by family paediatricians and were recovered by the PROSICS
community health team. Finally, two (6.9%) of the 29 newborns tested with serology were positive.
Conclusions: It is essential to implement active surveillance, education and information activities at paediatric
primary care and community levels to avoid the loss of CD-infected mothers and their newborns. Training sessions
addressed to paediatricians and other involved health professionals would consolidate surveillance and care
reference circuits, improving the control of congenital CD.
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Chagas disease (CD) is a parasitic disease caused by
Trypanosoma cruzi. Infection acquired through contact
with the contaminated faeces of triatomine bugs has been
the predominant route of transmission in Latin American
continental countries [1]. Prevalence is estimated in
around 8 million people and annual mortality in more* Correspondence: tsorianoarandes@gmail.com
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article, unless otherwise stated.than 10,000 people [2]. The distribution of the disease is
heterogeneous along the American continent, being
rural, periurban populations, and urban with low eco-
nomic status in South American countries the most
affected by CD [3,4].
In most infected patients the disease evolves silently
and chronically without any clinical symptoms. This
characteristic, which differs from other neglected tropical
diseases, is important for public health policies to prevent
transmission and control the disease in affected coun-
tries. Of those infected with T. cruzi, however, 30–40%d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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clinical manifestations [1], imposing an important cumu-
lative morbidity and mortality on affected families and a
heavy burden on the health systems of endemic and non-
endemic countries.
Important epidemiological changes in the disease have
occurred during the past decades [5,6]. After a series of
successful vectorial control achievements in many Latin
American countries, other transmission routes – such as
blood transfusion, congenital, oral, and organ transplant-
ation – have become more prominent since the 1990s.
Furthermore, the spread of the disease due to urbanization
and increased population movements between Latin
America and other continents has highlighted the import-
ance of detection and prevention in non-endemic coun-
tries [7]. In response to this new epidemiological context,
Spain launched Royal Decree 1008/2005 to screen T. cruzi
infection in all blood donors arriving from endemic areas
or in those previously subjected to blood transfusions
in Latin American continental countries [8]. However,
another transmission route – congenital transmission (i.e.
transmission from infected mothers to their children) – is
already an important challenge for Spain and other
endemic and non-endemic countries [9]. A recent article
aims to assess the frequency of congenital T. cruzi trans-
mission [10].
The first case of congenital Chagas disease in Spain
was detected in 2006 [11]. Since then, it has been esti-
mated that the rate of congenital CD among people at
risk of the infection is 0–13.8% in Spain [12]. Taking
into account these rates and the fecundity rate for Latin
American women in Europe, it is estimated that the
number of pregnant women with CD in Spain would be
of 1,400 per year and the number of T. cruzi infected
newborns between 53 and 93 per year [13].
Given the potential risk of congenital CD in Catalonia,
the Public Health Agency of Catalonia (ASPCAT) launched
the “Protocol for screening and diagnosing Chagas disease
in pregnant Latin American and their newborns” in 2010
[13], targeting Latin American pregnant women attending
antenatal consultations in Catalonia (Figure 1). The aim
of the Protocol is to detect T. cruzi-positive pregnant
women and follow up their offspring until 9 months of
age in order to elucidate their definitive CD status. The
implementation of information, education and commu-
nication activities was planned, including training of
health professionals working with CD detection and
treatment, and specific sessions for those working in
health centres with prenatal activities. Midwives, nurses,
obstetricians, primary health care physicians and paedi-
atricians attending these sessions were trained on T.
cruzi infection, diagnosis and its care, with focus on
congenital CD. According to the 2012 report of the Stat-
istical Institute of Catalonia (IDESCAT), 333,703 LatinAmerican immigrants were living in Catalonia (15.7%
from Bolivia), 6,795 newborns (15.4% from Bolivia) were
delivered by pregnant women at risk of CD and an esti-
mated 203–387 pregnant women (90% from Bolivia) were
infected with T. cruzi. The expected number of T. cruzi-
infected newborns was therefore 7–16 per year [14].
In order to monitor the implementation of the Protocol,
ASPCAT declared a total of 119 CD pregnant women
who had given birth in Catalonia, and 20% (24/119) of the
newborns were lost before serological control at 9 months
of age in 2010 [15]. In 2011, 179 pregnant women were di-
agnosed with CD in Catalonia: 24% (43/179) came from
one of the Catalan areas with the highest prevalence of
the affected population, the Municipality of Hospitalet del
Llobregat, with >250,000 inhabitants including 10% from
endemic areas [16] without any CD paediatric referral.
Community-based and culturally-sensitive actions to
manage CD in Europe are necessary because most
people at risk are migrants who have frequent difficulties
in accessing appropriate care. Furthermore, there are im-
portant challenges in screening newborns aged over
9 months after birth since the Protocol was launched in
2010 because diagnosis must be made with delayed sero-
logical tests. The aim of the study was to understand the
reasons for lack of or deficient follow up of newborns
from T.cruzi-infected mothers, and to apply and evaluate
an active strategy to detect T.cruzi infection among
those born from T. cruzi infected mothers. ASPCAT, in
coordination with the Unit of Tropical Medicine and
International Health of Vall Hebron-Drassanes, Inter-
national Health Programme of the Catalan Institute of
Health-PROSICS, planned a community health approach
with active surveillance to know the final serological sta-
tus and health condition of these children in relation to
T. cruzi infection.
Methods
Three meetings were held between ASPCAT and PRO-
SICS before the activities were initiated. One of the
inclusion criteria for active surveillance was being a T.
cruzi-infected pregnant woman resident in Hospitalet
de Llobregat and diagnosed before or during pregnancy.
The first step of active surveillance was to know the
final status of T. cruzi infection of children born from
these women. If the children were not controlled, the
PROSICS community health team solicited a visit with
the family to test the newborns and inform the family
about CD.
The presence of a PROSICS community health team
consisting of a paediatrician, two community health
nurses, a family physician working inside the community
and community health workers (CHW) with 20 years of
experience in the field of community mobilization, and
especially in CD since 2006, helped to find agreement on
Figure 1 Pathway for screening and diagnosis in pregnant women and newborns. (Source: Protocol for screening and diagnosing Chagas
disease in pregnant Latin American and their newborns.pdf; accessed 6 May 2014).
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hensive response.
1. Close active control of children born from
CD-positive mothers
When ASPCAT identified the list of T.cruzi-infected
pregnant women resident in Hospitalet de Llobregat in
2011 with no information about birth and possible new-
born follow-up, the PROSICS community health team was
consulted about starting active surveillance. Some CHW
activities were addressed to the Bolivian community. First,
CHW tried to locate the family by telephoning at different
times and days of the week (maximum 10 calls: morning,
afternoon, evening and weekends). When this activity
failed, either because the telephone number was not avail-
able or it was never answered, the CHW went to the home
(maximum 2 visits) to find any relative of the CD case;
finally, when the CHW found nobody at home, the neigh-
bours were asked if anyone was living there and a note was
left to call or to be addressed to PROSICS. If the CHW did
not locate the mother via telephone or at home, PROSICS
tried to find her in those community spaces frequented by
the Latin American population.
The designated CHW for this activity belongs to the
same Latin American community, facilitating knowledge
of this particular environment, its needs, problems, fears,
relationships, language and codes, and other forms of
communication.
Once the CHW located the mother, he took informa-
tion about the hospital of birth, parasitological controls
at birth, serological control at 9 months and primary
health care follow up. The PROSICS paediatrician coor-
dinated with the community nurses, made an appoint-
ment for a follow-up visit and a T. cruzi serological test
of uncontrolled children. Appointments were adapted to
the mother’s schedule because incompatible work times
are one of the reasons why mothers do not seek health
control visits.
2. Awareness and display of CD to the Latin
American community
PROSICS organized health promotion activities for
Latin American mothers living in the city of Hospitalet
del Llobregat. These included group workshops/ses-
sions held in social spaces (associations, partner health
centres, homes, community centres, community facil-
ities) and community awareness campaigns (fairs,
cultural events, recreational activities, newspapers for
the target population) with audiovisual material about
CD. During these activities the population was invited
to the health centre for screening in order to detect
and track CD cases.The participation and involvement of various non-
profit entities, partners, health services, religious
leaders, government and other stakeholders in various
health education activities was key to developing these
community-based actions.
A database was built including the most important
variables related to mothers (date of birth, age, family
address, country of origin, telephone number, year of
arrival in Spain, CD phase, primary health care centre,
laboratory where CD diagnosis was obtained, and date
of CD diagnosis), delivery of newborns (date, hospital,
confirmation of the delivery, screening of the newborn
at birth, and methods used for CD screening), and follow
up of children (cause of loss to follow up obtained by
the CHW and the paediatrician).
Ethical clearance for this research was not performed
because data registration of the children born to a CD
mother is mandatory following the 2010 launch in
Catalonia of the Protocol.
Results
Overall, 43/179 (24%) cases of T.cruzi-infected preg-
nant women who gave birth in 2011 met the inclusion
criteria for the study. One case was excluded because
negative CD status was later confirmed. Of these total
cases, 35/42 (83.3%) pregnant women gave birth to a
live newborn in Catalonia; 4/42 (16.7%) returned to
their country of origin before delivery; 2/42 miscarried
and 1/42 was stillborn. Regarding the country of origin,
90.5% (38/42) were Bolivian pregnant women. A total
of 67% of pregnant women were in the chronic phase
and indeterminate form. The mean age was 31.3 (SD
5.52; range: 21–44). At the time of CD diagnosis, 74%
of cases were diagnosed during gestation, 21% were di-
agnosed before gestation, and none was diagnosed dur-
ing delivery. The paediatrician of PROSICS recovered
follow-up information from 31/35 identified newborns;
the remaining 4 cases probably left Catalonia between
birth and surveillance. Of the 31 recovered infants, 12
were regularly controlled at 9 months of age in hospi-
tals outside the city of Hospitalet de Llobregat, but this
information was not communicated to ASPCAT. The
other 19 births in the General Hospital of Hospitalet de
Llobregat, should have been controlled in primary
health centres because there was no CD paediatric
referent in that hospital. Only 5/19 were correctly
followed up by family paediatricians; the remaining 14
(73.7%) were therefore not correctly tested for T. cruzi at
9 months of age. When parents were asked why their
children had not been screened at a primary health
centre, the response was that neither the paediatrician
nor the paediatric nurses had been reminded to solicit T.
cruzi serology at that age. As a result, 14 children with
unknown serological status underwent serology control
Figure 2 Summary of congenital Chagas disease community
health actions.
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not attend the visit and were not tested for CD.
Finally, of the 29/31 newborns without information
about serological status 2 were positive, which means a
congenital CD transmission rate of 6.9%.
Community health action recovered 73.8% (31/42) of
the CD cases for whom final information had not been
communicated to the ASPCAT through telephone calls
(17 cases), community activities (13 cases) and home visits
(1 case). The results of follow-up and community health
action are shown in Table 1 and Figure 2 respectively.
Discussion
ASPCAT initiated diagnosis of congenital CD in 2010
with the aim of controlling all pregnant women originat-
ing from Latin America who had attended the sexual
and reproductive units in Catalonia. Spain. The cost-
effectiveness of screening for CD in pregnant women from
Latin America in non-endemic areas has already been
demonstrated [17]. All pregnant women in Catalonia have
a health handbook in which midwives and obstetricians
register all the controls that have been carried out during
visits. According to the Protocol, the handbook provides a
new space to register whether Latin American pregnant
woman have been screened for CD during pregnancy.
After a few months of application of the Protocol, mid-
wives were aware of CD because most of the eligible
women had registered their CD status in the gestation
handbook as collected as a representative sample in differ-
ent primary health centres.
Despite such effective control during pregnancy, ASP-
CAT was unable to determine the final CD status for 20%
of the newborns in 2010. Of importance from a paediatric
point of view, most of the CD-infected newborns wereTable 1 Summary of follow-up of cases
N %
Pregnant women with unknown follow-up 42
Miscarriages/stillbirths 3/42 7%
Left country before birth 4/42 10%
Newborns to follow-up 35/42 83%
Recovered newborns 31/35 89%
Infants controlled at 9m-old by paediatricians
at hospitals
12/31 39%
Infants needed for foolow-up in
Primary Health Centres
19/31 61%
Infants without correct follow-up in
Primary Health Centres
14/19 74%
Controlled newborns 29/31 94%
Positive T. cruzi newborns 2/29 6.9%
(Source: Informe annual 2010 - Vigilància epidemiològica del protocol de
cribratge I diagnòstic de la malaltia de Chagas en dones embarassades
llatinoamericanes i els seus nadons. Agència de Salut Pública de Catalunya.
Generalitat de Catalunya, 2010).asymptomatic, generating a false perception that the new-
born was not infected with T. cruzi [18]. Follow up of
these newborns is important, however, because it has been
shown that prompt treatment during the first 12 months
of life cures all of them for a lifetime [19,20].
It has been demonstrated also that screening for CD
in pregnant women or newborns provides an opportun-
ity to detect further cases among siblings and relatives
as infections often occur in clusters [21]. Only a few cit-
ies or regions in Western Europe have implemented
screening programmes for congenital CD; Catalonia was
one of the first to apply a Protocol for this issue [14].
Contact between hospitals, ASSIRs and primary health
care paediatricians, however, must be improved. One of
the likely causes of the need for such active surveillance
is the lack of good networking between different health
providers in this setting, which is insufficient and needs
to be strengthened.
The poor control of newborns from CD-positive
mothers in paediatric primary health care centres high-
lights the need for training in congenital CD addressed to
those paediatricians. Equally important are actions to
improve coordination among different health actors.
Community health actions as “expert patient woman”
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Latin American community about the importance of
control in children to detect congenital CD transmission.
Experience to date suggests that the most effective strat-
egies are those that promote “face-to-face” actions among
influential groups organized into networks of community
action.
This model could be key in strategies proposed by epi-
demiological surveillance programmes and may be transfer-
able to other areas [22,23]. This is a long-term investment
that benefits the entire community. Finally, but no less im-
portantly, are the sociocultural aspects of CD [24,25], which
should be taken into account in order to improve know-
ledge of the feelings of CD mothers when they learn that
their offspring are at risk for T. cruzi infection. It should be
fundamental that pregnant CD-infected women understand
the need for their children to be followed-up during the
first year of life to rule out the possibility of congenital T.
cruzi infection to them.
Conclusions
It is essential to implement active surveillance, education
and information activities at paediatric primary care and
community levels to avoid the loss of CD-infected
mothers and their newborns. Training sessions addressed
to paediatricians and other involved health professionals
would consolidate surveillance and care reference circuits
and improve the control of congenital CD.
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